Arunjyoti Bio [ABVL] vs PDS [PDSL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Arunjyoti Bio Ventures Ltd. wins in 4 metrics, PDS Ltd. wins in 15 metrics, with 0 ties. PDS Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Arunjyoti Bio Ventures Ltd. | PDS Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 55.46 | 37.65 | PDS Ltd. |
| Price-to-Book Ratio | 4.38 | 2.38 | PDS Ltd. |
| Debt-to-Equity Ratio | 71.24 | 70.40 | PDS Ltd. |
| PEG Ratio | -0.53 | -0.52 | PDS Ltd. |
| EV/EBITDA | 26.00 | 15.46 | PDS Ltd. |
| Profit Margin (TTM) | -6.61% | 0.82% | PDS Ltd. |
| Operating Margin (TTM) | 8.92% | 2.44% | Arunjyoti Bio Ventures Ltd. |
| EBITDA Margin (TTM) | 8.92% | 2.44% | Arunjyoti Bio Ventures Ltd. |
| Return on Equity | -5.63% | 9.14% | PDS Ltd. |
| Return on Assets (TTM) | -3.06% | 3.31% | PDS Ltd. |
| Free Cash Flow (TTM) | $-44.22M | $-1.80B | Arunjyoti Bio Ventures Ltd. |
| Dividend Yield | N/A | 0.94% | N/A |
| 1-Year Return | -31.33% | -31.12% | PDS Ltd. |
| Price-to-Sales Ratio (TTM) | 6.11 | 0.31 | PDS Ltd. |
| Enterprise Value | $1.56B | $43.13B | PDS Ltd. |
| EV/Revenue Ratio | 6.04 | 0.33 | PDS Ltd. |
| Gross Profit Margin (TTM) | 100.00% | 22.68% | Arunjyoti Bio Ventures Ltd. |
| Revenue per Share (TTM) | $1 | $930 | PDS Ltd. |
| Earnings per Share (Diluted) | $-0.09 | $7.61 | PDS Ltd. |
| Beta (Stock Volatility) | 0.21 | -0.05 | PDS Ltd. |
Arunjyoti Bio Ventures Ltd. vs PDS Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Arunjyoti Bio Ventures Ltd. | -2.60% | -3.75% | -17.84% | -32.54% | -32.03% | -34.98% |
| PDS Ltd. | 0.50% | 0.20% | 7.88% | 1.45% | -13.94% | -19.24% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Arunjyoti Bio Ventures Ltd. | -31.33% | -68.54% | 228.82% | 202.16% | 326.72% | 195.77% |
| PDS Ltd. | -31.12% | -8.66% | 52.91% | 755.61% | 536.34% | 536.34% |
Performance & Financial Health Analysis: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.
| Metric | ABVL | PDSL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.58B | ₹40.46B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 2,838,634 | 124,606 |
| 90 Day Avg. Volume | 1,898,848 | 575,541 |
| Last Close | ₹5.25 | ₹303.30 |
| 52 Week Range | ₹5.05 - ₹12.71 | ₹246.05 - ₹433.90 |
| % from 52W High | -58.69% | -30.10% |
| All-Time High | ₹30.07 (Jan 15, 2024) | ₹666.00 (Nov 13, 2023) |
| % from All-Time High | -82.54% | -54.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.02% |
| Quarterly Earnings Growth | 0.05% | -0.21% |
| Financial Health | ||
| Profit Margin (TTM) | -0.07% | 0.01% |
| Operating Margin (TTM) | 0.09% | 0.02% |
| Return on Equity (TTM) | -0.06% | 0.09% |
| Debt to Equity (MRQ) | 71.24 | 70.40 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.93 | ₹120.55 |
| Cash per Share (MRQ) | ₹0.01 | ₹74.31 |
| Operating Cash Flow (TTM) | ₹-12,115,000 | ₹-574,170,000 |
| Levered Free Cash Flow (TTM) | ₹-18,215,000 | ₹1.57B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.94% |
| Last 12-Month Dividend | N/A | ₹3.35 |
Valuation & Enterprise Metrics Analysis: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.
| Metric | ABVL (Apr 26, 2026) | PDSL (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 55.46 | 37.65 |
| Forward P/E | N/A | 25.81 |
| PEG Ratio | -0.53 | -0.52 |
| Price to Sales (TTM) | 6.11 | 0.31 |
| Price to Book (MRQ) | 4.38 | 2.38 |
| Market Capitalization | ||
| Market Capitalization | ₹1.58B | ₹40.46B |
| Enterprise Value | ₹1.56B | ₹43.13B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.04 | 0.33 |
| Enterprise to EBITDA | 26.00 | 15.46 |
| Risk & Other Metrics | ||
| Beta | 0.21 | -0.05 |
| Book Value per Share (MRQ) | ₹1.93 | ₹120.55 |
Financial Statements Comparison: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ABVL (2025) | PDSL (2025) |
|---|---|---|
| Revenue/Sales | 278.84M | 121.00B |
| Cost of Goods Sold | 114.29M | 101.25B |
| COGS % of Revenue | 41.0% | 83.7% |
| Gross Profit | 164.55M | 19.75B |
| Gross Margin | 59.0% | 16.3% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 19.68M | 3.88B |
| Operating Margin | 7.1% | 3.2% |
| EBITDA | 52.95M | 4.88B |
| EBITDA Margin | 19.0% | 4.0% |
| Pre-Tax Income | -3.41M | 2.68B |
| Pre-Tax Income % of Revenue | -1.2% | 2.2% |
| Income Tax | 14.81M | 271.15M |
| Income Tax % of Revenue | 5.3% | 0.2% |
| Net Income (Profit) | -18.22M | 2.41B |
| Profit Margin | -6.5% | 2.0% |
Balance Sheet & Liquidity Metrics
| Metric | ABVL (2025) | PDSL (2025) |
|---|---|---|
| Cash & Equivalents | 5.92M | 4.35B |
| Total Current Assets | 147.98M | 35.12B |
| Total Current Assets % of Revenue | 53.1% | 29.0% |
| Total Current Liabilities | 52.90M | 27.94B |
| Total Current Liabilities % of Revenue | 19.0% | 23.1% |
| Long-Term Debt | 214.50M | 1.92B |
| Long-Term Debt % of Revenue | 76.9% | 1.6% |
| Total Shareholders Equity | 323.80M | 17.16B |
| Retained Earnings | -30.59M | 8.11B |
| Retained Earnings % of Revenue | -11.0% | 6.7% |
| Property, Plant & Equipment | 71.31M | 2.96B |
Cash Flow Statement Comparison
| Metric | ABVL (2025) | PDSL (2025) |
|---|---|---|
| Operating Cash Flow | -12.12M | -574.17M |
| Operating Cash Flow % of Revenue | -4.3% | -0.5% |
| Capital Expenditures | -58.72M | -909.35M |
| Free Cash Flow | -44.22M | -1.80B |
| FCF Margin | -15.9% | -1.5% |
| Debt Repayment | N/A | -41.67M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ABVL | PDSL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 186.38M | 141.22M |
| Float Shares | 11.37M | 26.91M |
| % Held by Insiders | 68.86% | 71.87% |
| % Held by Institutions | 0.00% | 5.08% |
| % Held by Public | 31.14% | 23.05% |
Dividend Analysis & Yield Comparison: Arunjyoti Bio Ventures Ltd. vs PDS Ltd.
| Metric | ABVL | PDSL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹3.35 |
| Last 12-Month Dividend Yield | N/A | 0.94% |
| 3-Year Avg Annual Dividend | N/A | ₹4.12 |
| 3-Year Avg Dividend Yield | N/A | 0.48% |
| 3-Year Total Dividends | N/A | ₹12.35 |
| Ex-Dividend Date | N/A | Oct 31, 2025 |